These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24304342)

  • 1. Risk predictive modelling for diabetes and cardiovascular disease.
    Kengne AP; Masconi K; Mbanya VN; Lekoubou A; Echouffo-Tcheugui JB; Matsha TE
    Crit Rev Clin Lab Sci; 2014 Feb; 51(1):1-12. PubMed ID: 24304342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the importance of global cardiovascular risk assessment in people with type 2 diabetes.
    Echouffo-Tcheugui JB; Kengne AP
    Prim Care Diabetes; 2013 Jul; 7(2):95-102. PubMed ID: 23623209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus.
    Echouffo-Tcheugui JB; Kengne AP
    Diabetes Metab; 2013 Oct; 39(5):389-96. PubMed ID: 24080092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk prediction models: II. External validation, model updating, and impact assessment.
    Moons KG; Kengne AP; Grobbee DE; Royston P; Vergouwe Y; Altman DG; Woodward M
    Heart; 2012 May; 98(9):691-8. PubMed ID: 22397946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus.
    van der Leeuw J; van Dieren S; Beulens JW; Boeing H; Spijkerman AM; van der Graaf Y; van der A DL; Nöthlings U; Visseren FL; Rutten GE; Moons KG; van der Schouw YT; Peelen LM
    Heart; 2015 Feb; 101(3):222-9. PubMed ID: 25256148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker.
    Moons KG; Kengne AP; Woodward M; Royston P; Vergouwe Y; Altman DG; Grobbee DE
    Heart; 2012 May; 98(9):683-90. PubMed ID: 22397945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.
    Mendis S
    Prog Cardiovasc Dis; 2010; 53(1):10-4. PubMed ID: 20620420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory and non-laboratory-based risk prediction models for secondary prevention of cardiovascular disease: the LIPID study.
    Cui J; Forbes A; Kirby A; Simes J; Tonkin A
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):660-8. PubMed ID: 19738473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review.
    van Dieren S; Beulens JW; Kengne AP; Peelen LM; Rutten GE; Woodward M; van der Schouw YT; Moons KG
    Heart; 2012 Mar; 98(5):360-9. PubMed ID: 22184101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are diabetes risk scores useful for the prediction of cardiovascular diseases? Assessment of seven diabetes risk scores in the KORA S4/F4 cohort study.
    Kowall B; Rathmann W; Bongaerts B; Thorand B; Belcredi P; Heier M; Huth C; Rückert IM; Stöckl D; Peters A; Meisinger C
    J Diabetes Complications; 2013; 27(4):340-5. PubMed ID: 23659777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular risk assessment for informed decision making. Validity of prediction tools].
    Lenz M; Mühlhauser I
    Med Klin (Munich); 2004 Nov; 99(11):651-61. PubMed ID: 15583875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer programs to estimate overoptimism in measures of discrimination for predicting the risk of cardiovascular diseases.
    Mannan HR; McNeil JJ
    J Eval Clin Pract; 2013 Apr; 19(2):358-62. PubMed ID: 22409210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk assessment in diabetes mellitus: comparison of the general Framingham risk profile versus the World Health Organization/International Society of Hypertension risk prediction charts in Arabs--clinical implications.
    Al-Lawati JA; Barakat MN; Al-Lawati NA; Al-Maskari MY; Elsayed MK; Mikhailidis DP; Al-Zakwani IS
    Angiology; 2013 Jul; 64(5):336-42. PubMed ID: 22942129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock.
    Kengne AP; Turnbull F; MacMahon S
    Prog Cardiovasc Dis; 2010; 53(1):45-51. PubMed ID: 20620425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evolving Cardiovascular Disease Risk Scores for Persons with Diabetes Mellitus.
    Zhao Y; Wong ND
    Curr Cardiol Rep; 2018 Oct; 20(12):126. PubMed ID: 30310997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
    Mosca L; Linfante AH; Benjamin EJ; Berra K; Hayes SN; Walsh BW; Fabunmi RP; Kwan J; Mills T; Simpson SL
    Circulation; 2005 Feb; 111(4):499-510. PubMed ID: 15687140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.